Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Gao

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering|November 17, 2001
[Determination of +Gz tolerance end-point by steady state visual evoked potential]L Zhang, S K Gao, Q Wu
IEEE Transactions on Bio-Medical Engineering|May 11, 2004
A novel speech-processing strategy incorporating tonal information for cochlear implantsN Lan, K B Nie, S K Gao, et al.
Methods of Information in Medicine|July 13, 2000
Spatio-temporal nonlinear modeling of gastric myoelectrical activityZ S Wang, J Y Cheung, S K Gao, et al.
Zhonghua Nei Ke Za Zhi|October 1, 2016
[The efficacy analysis of interferon combined with imatinib in chronic myelogenous leukemia patients with ABL kinase domain mutations]Y L Zu, Y L Zhang, J Zhou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Hang Tian Yi Xue Yu Yi Xue Gong Cheng = Space Medicine & Medical Engineering|November 17, 2001
[Determination of +Gz tolerance end-point by steady state visual evoked potential]L Zhang, S K Gao, Q Wu
IEEE Transactions on Bio-Medical Engineering|May 11, 2004
A novel speech-processing strategy incorporating tonal information for cochlear implantsN Lan, K B Nie, S K Gao, et al.
Methods of Information in Medicine|July 13, 2000
Spatio-temporal nonlinear modeling of gastric myoelectrical activityZ S Wang, J Y Cheung, S K Gao, et al.
Zhonghua Nei Ke Za Zhi|October 1, 2016
[The efficacy analysis of interferon combined with imatinib in chronic myelogenous leukemia patients with ABL kinase domain mutations]Y L Zu, Y L Zhang, J Zhou, et al.
Pageof 1